The therapeutic potential of modifying inflammasomes and NOD-like receptors
about
Biochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteinsPathogenesis of infection in surgical patientsNLRP3 inflammasome: activation and regulation in age-related macular degenerationDelivery of host cell-directed therapeutics for intracellular pathogen clearanceIdentification of multifaceted binding modes for pyrin and ASC pyrin domains gives insights into pyrin inflammasome assembly.Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.Interferon-stimulated genes: a complex web of host defenses.Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease.Vinpocetine inhibits amyloid-beta induced activation of NF-κB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cellsThe activation of pyrin domain-containing-3 inflammasome depends on lipopolysaccharide from Porphyromonas gingivalis and extracellular adenosine triphosphate in cultured oral epithelial cellsA Dual Role for P2X7 Receptor during Porphyromonas gingivalis InfectionActivation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer diseaseExtracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.Comparative study of the P2X gene family in animals and plants.Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death.Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression.Introduction and perspective, historical note.The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccinationInflammasomes in cancer: a double-edged sword.ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis!NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke.Pattern recognition receptors and central nervous system repair.Do inflammatory pathways drive melanomagenesis?The inflammasome as a target for pain therapy.What do we know about the inflammasome in humans?The P2X7 Receptor-Interleukin-1 Liaison.Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.Structural and functional insights into CARDs of zebrafish (Danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2.Brilliant Blue G, But Not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease.Inflammasomes, the eye and anti-inflammasome therapy.TLRs/NLRs: Shaping the landscape of host immunity.NLR-Dependent Regulation of Inflammation in Multiple Sclerosis- Dependent Regulation of Inflammation in Multiple Sclerosis.Identifying progression related disease risk modules based on the human subcellular signaling networks.Differential expression of inflammasomes in lung cancer cell lines and tissues.Identification of the Q969R gain-of-function polymorphism in the gene encoding porcine NLRP3 and its distribution in pigs of Asian and European origin.
P2860
Q26852840-B3316239-0544-4506-A059-340551C9030BQ26995283-06CA1C97-6F81-4BB6-A719-D6EAC4AFE22BQ26995315-67C06240-0BF9-4D06-B15C-889FD0947DEFQ27006858-4C41E502-BAA6-48BA-888F-91DEC1655CC7Q30668589-E965F959-6A21-43B6-A423-0F87CEC85FBDQ33816592-CDC78FCA-53BB-4724-9933-C444F2138F73Q34405609-9EC2A683-0523-44AF-BE40-084C7E294B53Q34702157-A0FE4365-3E1E-401C-A4CC-5C72F547B723Q35705361-8A70FE16-5567-4704-9A2D-8EECBFE0ACD3Q35825064-AF5B0F82-91FB-4B77-BC6A-9828C2778D09Q35990102-580FD37C-A54E-4A03-A9C2-9EE4A4B57759Q36508719-394B7970-AD3A-4D31-8433-64908E89BE05Q36568428-FEEF26A7-7AD9-47E2-A086-ABDDC814AE28Q36804513-BB883DE5-D35C-46FE-9ADC-AFDC108F9FA3Q36863566-22AA93E4-86EF-4C62-9BCE-76FA5D19DA06Q36933964-E4AE0992-7B44-4151-90FE-000B7E21020DQ37299370-E4ADB813-8AB2-4E4B-B23D-26AF6EC33809Q37330911-3C0B63E4-67E0-4321-9312-D7263E0C3FC0Q37421379-91CA650E-5664-4087-82AF-A45FD7866690Q37610512-1FA21F19-CCB9-4340-A632-0524B4505BD8Q37680218-2C1FEEE2-D36D-4AD1-9891-460FB045B714Q37693490-087E96F4-839C-4332-9D31-34A447A7A79CQ37695325-F5A772C0-263F-4675-B76B-F32C48FD1C5DQ38228956-984601B0-491B-4B0A-887C-6C81EDAFDD2DQ38231601-4F194B97-F126-4976-8F04-33D0041D5C59Q39036848-2871A898-C217-4794-92A7-1EA3BA3D8A31Q39044487-FB2CD73F-407F-4505-A0F2-DBF883DF6E31Q39209974-4F4795FD-45E8-454F-9183-7F38BB740612Q40274003-E6D13AEB-D41C-44B1-A399-DAE1FA1CB3DCQ47073301-B6E36FBD-B6BF-40CD-AC4B-212961030953Q47144890-D40A4C0E-B503-4D46-9E4A-40B0A8DF2363Q47368616-CA95BC25-B9D4-4B72-AD18-6BE424CCD412Q47570715-01A72F7F-E078-4542-BDE2-61DA36AFFDA8Q49516622-5210268D-8245-4FFF-BC50-D55545F3120FQ51024931-8BA3C157-AFCF-440D-9FFE-8EA90875E96FQ51637026-B730164F-2213-4AEE-9EBF-CAE561D04653Q52866944-351A193D-5DBF-45E0-9500-33A13A3AF887
P2860
The therapeutic potential of modifying inflammasomes and NOD-like receptors
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@ast
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@en
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@nl
type
label
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@ast
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@en
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@nl
prefLabel
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@ast
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@en
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@nl
P3181
P356
P1476
The therapeutic potential of modifying inflammasomes and NOD-like receptors
@en
P2093
F. Di Virgilio
P304
P3181
P356
10.1124/PR.112.006171
P407
P577
2013-04-16T00:00:00Z